GTR07524878

HDAC-IN-63

ml-lentiviral-shrna

Ask for quotation

Description

HDAC-IN-63 (Compound 63) is a dual FLT3/HDAC inhibitor (IC50: 0.844 and 30.0 nM for FLT3 and HDAC1 respectively) . HDAC-IN-63 inhibits MV4-11 cell proliferation (IC50: 92 nM. HDAC-IN-63 induces apoptosis and arrests cell cycle in MV4-11 cells. HDAC-IN-63 can be used for research of acute myeloid leukemia (AML) [1].

Description

HDAC-IN-63 (Compound 63) is a dual FLT3/HDAC inhibitor (IC50: 0.844 and 30.0 nM for FLT3 and HDAC1 respectively) . HDAC-IN-63 inhibits MV4-11 cell proliferation (IC50: 92 nM. HDAC-IN-63 induces apoptosis and arrests cell cycle in MV4-11 cells. HDAC-IN-63 can be used for research of acute myeloid leukemia (AML) [1].

Variants

1 Each (HY-149474)Ask for price
Specifications Table·product-specifications

Related Products

GTR00902997

Frozen Tissue Section - Human Tumor: Liver

5 Slides
$581.87($769.52)
GTR00920515

P21WAF1 (Tumor Suppressor Protein) (AC8), Biotin conjugate, 0.1mg/mL

1x 100 µL
$264.92($350.36)
GTR00921380

Calretinin / Calbindin 2 (Mesothelioma Marker) (CALB2/2786), CF405S conjugate, 0.1mg/mL

1x 500 µL
$645.08($853.12)
GTR00935344

BCL10 (MALT-Lymphoma Marker) (151), CF568 conjugate, 0.1mg/mL

1x 100 µL
$264.92($350.36)